Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
2000 | 1 |
2001 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.
Am J Kidney Dis. 2001 Mar;37(3):532-43.
Am J Kidney Dis. 2001.
PMID: 11228177
Clinical Trial.
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
Frazão JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW.
Frazão JM, et al.
Am J Kidney Dis. 2000 Sep;36(3):550-61. doi: 10.1053/ajkd.2000.16193.
Am J Kidney Dis. 2000.
PMID: 10977787
Clinical Trial.
Item in Clipboard
Bronchoalveolar lavage in ventilated newborn infants: safety and tumor necrosis factor-alpha activity.
Belai YZ, Findlay RD, Lau AS, Walther FJ.
Belai YZ, et al.
J Perinatol. 1997 Sep-Oct;17(5):360-5.
J Perinatol. 1997.
PMID: 9373840
Item in Clipboard
Cite
Cite